BioSpace News Archive

Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, announced that Weston Miller, M.D., will join the company as chief medical officer effective October 23, 2023.

Genmab A/S announced that worldwide net trade sales of DARZALEX®, including sales of the subcutaneous product, as reported by Johnson & Johnson were USD 2,499 million in the third quarter of 2023.

Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is delighted to announce the presentation of two posters at the upcoming ESGCT Annual Meeting on 24-27 October 2023, in Brussels, Belgium.

Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced interim data from the Phase 1 dose escalation part of its ongoing Phase 1/2 open-label, multicenter study of MRT-2359 in patients with MYC-driven solid tumors, including lung cancers and high-grade neuroendocrine cancer.

ProSciento, Inc. is pleased to announce that they are a recipient of the 2023 Innovation Award from The Liver Coalition of San Diego, champions for liver health and patient support in the region.

Radionetics Oncology, Inc., a clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, is pleased to announce that the first subject has been dosed in its Phase 1 study of 68Ga-R8760.